| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.7M | +72.6% |
| Cost of Revenue | $12.5M | +130.6% |
| Gross Profit | $4.2M | -1.5% |
| R&D Expense | $2.0M | +0.0% |
| SG&A Expense | $4.7M | -21.8% |
| Operating Income | -$1.9M | +64.0% |
| Pre-tax Income | -$4.0M | +28.1% |
| Income Tax | -$581K | — |
| Net Income | -$3.4M | +38.5% |
| EPS (Basic) | -$0.17 | +88.5% |
| EPS (Diluted) | -$0.17 | +88.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.7M | +4043.5% |
| Accounts Receivable | $2.4M | +6623.1% |
| Inventory | $2.2M | -23.4% |
| Current Assets | $11.8M | +48.6% |
| Total Assets | $35.5M | +258.4% |
| Current Liabilities | $2.4M | -58.9% |
| Total Liabilities | $7.6M | +11.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$446K | +68.0% |
| Capital Expenditures | $14K | +0.0% |
| Investing Cash Flow | -$22.8M | — |
| Financing Cash Flow | $29.8M | +2430.9% |
| Free Cash Flow | -$460K | +67.3% |
| $28.0M |
| +795.1% |